23 May 2013
Keywords: fda, clears, nutropin, aq, pen, food, drug
Article | 29 April 2002
The US Food and Drug Administration has cleared Genentech's NutropinAQ Pen (somatropin [rDNA origin] injection), for long-term treatment
of growth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 April 2002
22 May 2013
© 2013 thepharmaletter.com